How GSK Are Revolutionizing HTE

High-throughput experimentation has reshaped how medicinal chemists approach reaction optimization, but scaling these workflows introduces new challenges around data capture, reproducibility, and analysis. By miniaturizing reactions to plate-based formats, discovery teams can evaluate more variables in parallel, reduce material consumption, and accelerate project timelines. The real hurdle lies in managing the complexity of thousands of reactions and analytical outputs without introducing errors or inefficiencies.

This case study explores how GSK transformed its HTE capabilities by moving away from fragmented tools toward a unified, workflow-driven digital environment. Real-world examples—from Buchwald–Hartwig couplings to direct-to-biology strategies—show how standardized experiment design, automated data handling, and advanced visualization enable faster, more confident decision-making. The result is a lower barrier to HTE adoption and a foundation for future AI- and data science–driven discovery.

See how these approaches translate into everyday lab impact.